Azar said that any approach to bring down drug prices that does not tackle pharmacy benefit manager rebates “will not deliver the results.”

As they pay more for healthcare and expect technology to enable their interactions with service providers, consumers are now more engaged.

Executives insist the pharmacy benefit management space is a competitive one, but industry watchers aren't so sure.

The Trump administration will appeal a judge’s decision to block Medicaid work requirements in two states. 

Healthcare and health IT groups are supporting recently proposed legislation aimed at reforming a patient privacy regulation by aligning it with HIPAA.

Hospital leaders were treated to opposing arguments from the nation's top congressional leaders headed to the AHA's annual meeting Tuesday.

Pharmacy benefit managers warn that eliminating drug rebates puts little pressure on pharmaceutical companies to drive down costs.

The Trump administration is interested in the concept of creating post-acute care bundles, the head of the CMMI told an audience on Monday.